Cargando…
Unleashing the tiger – iatrogenic autoimmunity from cancer immunotherapy drugs
Immune checkpoint inhibitors can lead to the development of organ and non-organ specific immune related adverse events.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761926/ https://www.ncbi.nlm.nih.gov/pubmed/29344404 http://dx.doi.org/10.1177/2054270417746905 |